Glibornuride

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Glibornuride 是 ATP 敏感 K+ 通道阻断剂 (pKi: 5.75)。格列波脲可抑制高亲和力 [3H]-格列本脲的结合，并具有 K+ 通道活性所预期的效力。

Glibornuride is a blocker of ATP-sensitive K+ channel(pKi: 5.75). Glibornuride inhibits high affinity [3H]-glibenclamide binding with the potencies expected from their K+ channel activity.(In Vivo):The diabetic group, given Glibornuride(5mg/kg), blood glucose, serum alkaline phosphatase activity, serum sialic acid, uric acid, potassium, and liver NEG levels decreased, but liver LPO, GSH, serum sodium levels, and body weight increased.

——

Animal Model:6-6.5-month-old male Swiss Albino rats, weighing 150-200 g Dosage:5 mg/kg Administration:Given by gavage, daily for 28 days Result:Administration for 28 days caused an increase in body weights in the diabetic groups. Treatment for 28 days decreased the serum uric acid levels in diabetic rats.

——

Cell Cycle/DNA Damage

Potassium Channel

——

——

——

26944-48-9

366.48

C18H26N2O4S

>98% (HPLC)

In Vitro:?DMSO : 250 mg/mL (682.17 mM)

[H][C@@]12CC[C@@](C)([C@@H](O)[C@H]1NC(=O)NS(=O)(=O)c1ccc(C)cc1)C2(C)C

——

(-20℃)

With Ice Pack

≥ 2 years